Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Effects of Consuming a Low-Fat Yogurt Fortified With Nano Encapsulated Vitamin D on Serum Pro-Oxidant-Antioxidant Balance (Pab) in Adults With Metabolic Syndrome; a Randomized Control Trial Publisher Pubmed

Summary: A study found vitamin D-fortified yogurt reduces inflammation in adults with metabolic syndrome, aiding health. #Nutrition #MetabolicHealth

Taghizadeh N1 ; Sharifan P2, 4 ; Ekhteraee Toosi MS1 ; Najar Sedgh Doust F1 ; Darroudi S3 ; Afshari A2 ; Rezaie M2 ; Safarian M2 ; Vatanparast H5 ; Eslami S6 ; Ghazizadeh H3, 4 ; Khorasanchi Z2 ; Bagherniya M7 ; Ferns G8 Show All Authors
Authors
  1. Taghizadeh N1
  2. Sharifan P2, 4
  3. Ekhteraee Toosi MS1
  4. Najar Sedgh Doust F1
  5. Darroudi S3
  6. Afshari A2
  7. Rezaie M2
  8. Safarian M2
  9. Vatanparast H5
  10. Eslami S6
  11. Ghazizadeh H3, 4
  12. Khorasanchi Z2
  13. Bagherniya M7
  14. Ferns G8
  15. Assaran Darban R1
  16. Ghayourmobarhan M2, 3

Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews Published:2021


Abstract

Background and aim: The current study aimed to assess the effect of fortified yogurt with nano-encapsulated vitamin D on serum pro-oxidant anti-oxidant balance (PAB) in adults with or without metabolic syndrome. Methods: In a quadruple blind clinical trial study, 139 adults with an age range of 30–50 years were randomly selected to receive either 1500 IU nano-encapsulated vitamin D fortified yogurt or placebo for ten weeks. Before and after the intervention period, blood sample was taken to determine the serum levels of vitamin D, pro-oxidant-antioxidant balance (PAB), and high-sensitivity C-reactive protein (hs-CRP). The laboratory tests were checked at baseline and at the end of the treatment. Results: Serum vitamin D increased significantly, from 14.47 ± 6.07 ng/mL to 21.39 ± 6.54 ng/mL (P < 0.001) after ten weeks in the intervention group. Serum hs-CRP and PAB were significantly lower following consumption period in intervention group [1.95(0.4–8.15) g/dL vs. 1.35(0.25–3.62) g/dL; P = 0.013] and (135.19 ± 42.4 HK vs. 115.39 ± 44.69) HK; P = 0.018] respectively. There were no significant differences between the intervention and control groups regarding weight and BMI at the end of the intervention period (p > 0.05). Conclusion: Low-fat yogurt fortified with nano-encapsulated vitamin D was found to reduce serum PAB levels in adults with metabolic syndrome. Practical application: The findings of the present study indicated that a low-fat yogurt fortified with 1500 IU nano-encapsulated vitamin D for ten weeks, leads to a significant reduction in serum hs-CRP and PAB concentrations highlighted the anti-inflammatory/anti-oxidative effect of vitamin D. © 2021 Diabetes India
Other Related Docs
13. Vitamin D Level in Iranian Patients With Neuromyelitis Optica, Journal of Isfahan Medical School (2021)